With the widespread rollout of the vaccine and removal of mask mandates in many states, the COVID-19 pandemic has evolved. Some individuals have developed immunity through antibodies or vaccination, but others are still vulnerable, and they must alter their lives to stay safe in a...
As we continue to navigate COVID-19, we’re excited to see more and more people receive the vaccine and celebrate a Food and Drug Administration (FDA) approved treatment for COVID-19 — monoclonal antibody treatments. A new treatment presents new questions. Monoclonal antibody treatments are typically used...
Perhaps the most important key to success in the healthcare supply chain? Relationships. It is important to first foster dynamic collaboration between the various stops to ensure the supply chain is as effective as possible. For that to occur, we must first establish high confidence...
We know that an important aspect of successful healthcare supply chain design is the ability to prepare for likely pressures, but what about something that is nearly impossible to predict, like a pandemic? A pandemic can strike without warning — and often with many unknowns about how...
When a disaster strikes, the healthcare supply chain is resilient and is built to anticipate and react to disasters. Many protections are taken on the front end before a crisis ever occurs. As the supply chain is developed, complex systems are also put in place to...
Supply chains have been a hot topic since the start of the COVID-19 pandemic – everything from the production of toilet paper to the healthcare supply chain. Most Americans are unaware of the various aspects of the healthcare supply chain that allow patients to maintain their...
Unprecedented global collaboration between scientists has greatly accelerated understanding of the COVID-19 virus, the infection it causes, and the testing and development of therapies and vaccines to treat and prevent it. With new therapies and treatments on the market comes with new guidance. Please see...
Over a year into the COVID-19 pandemic, we are now experiencing hope as more and more people become fully vaccinated against COVID-19, but many questions still remain around what you can do once you are fully vaccinated and what treatments are available if you test...
Approximately 61 million people in the United States have a disability. People with disabilities are considered a high-risk group for COVID-19 – but often not because of their disability but due to underlying conditions such as heart disease, stroke, diabetes, or cancer. The most important risk for...
The disproportionate impacts of COVID-19 across communities of color is undeniable. In June, we shared an infographic showing some of the systemic inequities Blacks and Latinx groups face, including lower access to healthcare, higher incidence of comorbidities, and higher rates of contracting COVID-19 than for White counterparts. One year...
